A thorough medication review is essential to identify any drugs that might interfere with weight loss
Discuss what that means for your own symptom timing with your provider
Clinical trial data from the STEP program (Semaglutide Treatment Effect in People with obesity) documented average weight loss of 47% of baseline body weight by week 16
At the very least, we have laid a pathway for the prolonged release of therapeutic GLP-1based anti-diabetic and anti-obesity treatments that could have beneficial impact on type 2 diabetes management and, perhaps, other conditions as well, Appel said in the same statement
We serve clients from Tampa FL, Egypt Lake-Leto FL, Town n Country FL, Westchase FL, Temple Terrace FL, Lutz FL, Oldsmar FL, Keystone FL, Wesley Chapel FL, and surrounding areas